Quarterly report pursuant to Section 13 or 15(d)

Debt - Narrative (Details)

v3.19.3
Debt - Narrative (Details)
1 Months Ended 3 Months Ended 9 Months Ended 48 Months Ended
Feb. 20, 2019
USD ($)
Jan. 30, 2013
USD ($)
Feb. 28, 2019
USD ($)
day
$ / shares
shares
Feb. 28, 2018
USD ($)
$ / shares
Nov. 30, 2015
USD ($)
Jan. 31, 2013
Sep. 30, 2019
USD ($)
institution
Sep. 30, 2019
USD ($)
institution
shares
Sep. 30, 2018
USD ($)
Dec. 31, 2016
USD ($)
shares
Feb. 01, 2019
USD ($)
Dec. 31, 2018
USD ($)
institution
Nov. 08, 2018
USD ($)
Debt Instrument [Line Items]                          
Credit line capacity             $ 122,435,000 $ 122,435,000          
Repayments of lines of credit               158,477,000 $ 28,435,000        
Long-term line of credit, noncurrent             50,644,000 50,644,000       $ 105,198,000  
Goodwill             $ 695,798,000 $ 695,798,000       $ 700,193,000  
Number of financial institutions | institution             11 11       11  
BioReference                          
Debt Instrument [Line Items]                          
Net assets             $ 869,500,000 $ 869,500,000          
Goodwill             401,800,000 401,800,000          
Intangible assets             $ 375,600,000 $ 375,600,000          
OPKO Health Europe                          
Debt Instrument [Line Items]                          
Weighted average interest rate             2.70% 2.70%       2.10%  
Minimum                          
Debt Instrument [Line Items]                          
Consecutive days             30 days            
Minimum | OPKO Health Europe                          
Debt Instrument [Line Items]                          
Variable interest rates             1.30% 1.30%          
Maximum                          
Debt Instrument [Line Items]                          
Percentage of total revolving commitment             10.00%            
Maximum | OPKO Health Europe                          
Debt Instrument [Line Items]                          
Variable interest rates             3.80% 3.80%          
Convertible Debt                          
Debt Instrument [Line Items]                          
Interest rate on notes payable     4.50%                    
Convertible Debt | Convertible Senior Notes Due 2025                          
Debt Instrument [Line Items]                          
Debt face amount     $ 200,000,000.0                    
Conversion rate     0.2367                    
Conversion price per share (in dollars per share) | $ / shares     $ 4.22                    
Shares issuable under debt agreement (in shares) | shares     30,000,000                    
Shares issued on converted debt (in shares) | shares               29,250,000          
Proceeds one-time nominal fee               $ 300,000          
Equity component of convertible debt     $ 52,600,000                    
Effective interest rate             11.20% 11.20%          
Convertible Debt | Convertible Senior Notes Due 2025 | Redemption period one                          
Debt Instrument [Line Items]                          
Convertible debt, threshold percentage of stock price trigger     130.00%                    
Equivalent redemption price     100.00%                    
Convertible Debt | Convertible Senior Notes Due 2025 | Redemption period one | Minimum                          
Debt Instrument [Line Items]                          
Number of trading days | day     20                    
Convertible Debt | Convertible Senior Notes Due 2025 | Redemption period one | Maximum                          
Debt Instrument [Line Items]                          
Number of consecutive trading days applicable conversion price | day     30                    
Convertible Debt | Convertible Senior Notes Due 2025 | Redemption period two                          
Debt Instrument [Line Items]                          
Convertible debt, threshold percentage of stock price trigger     98.00%                    
Convertible Debt | Convertible Senior Notes Due 2025 | Redemption period two | Minimum                          
Debt Instrument [Line Items]                          
Number of trading days | day     5                    
Convertible Debt | Convertible Senior Notes Due 2025 | Redemption period two | Maximum                          
Debt Instrument [Line Items]                          
Number of consecutive trading days applicable conversion price | day     5                    
Convertible Debt | Convertible Senior Notes Due 2025 | Redemption period three                          
Debt Instrument [Line Items]                          
Convertible debt, threshold percentage of stock price trigger     130.00%                    
Equivalent redemption price     100.00%                    
Convertible Debt | Convertible Senior Notes Due 2025 | Redemption period three | Minimum                          
Debt Instrument [Line Items]                          
Number of trading days | day     20                    
Convertible Debt | Convertible Senior Notes Due 2025 | Redemption period three | Maximum                          
Debt Instrument [Line Items]                          
Number of consecutive trading days applicable conversion price | day     30                    
Convertible Debt | 5% Convertible Notes                          
Debt Instrument [Line Items]                          
Debt face amount       $ 55,000,000.0                  
Interest rate on notes payable       5.00%                  
Conversion price per share (in dollars per share) | $ / shares       $ 5.00                  
Maturity duration       5 years                  
Minimum conversion notice       30 days                  
Maximum conversion notice       60 days                  
Convertible Debt | Notes Due February 1, 2033                          
Debt Instrument [Line Items]                          
Converted debt amount                   $ 143,200,000      
Senior Notes                          
Debt Instrument [Line Items]                          
Remaining principal             $ 146,260,000 $ 146,260,000       $ 0  
Senior Notes | Notes Due February 1, 2033                          
Debt Instrument [Line Items]                          
Debt face amount   $ 175,000,000.0                      
Interest rate on notes payable   3.00%                      
Equivalent redemption price   100.00%                      
Notes | Notes Due February 1, 2033                          
Debt Instrument [Line Items]                          
Equivalent redemption price           100.00%              
Debt repurchase amount                     $ 28,800,000    
Remaining principal                     $ 3,000,000.0    
Line of Credit                          
Debt Instrument [Line Items]                          
Weighted average interest rate             4.40% 4.40%       4.70%  
Line of Credit | Unsecured Debt                          
Debt Instrument [Line Items]                          
Interest rate on notes payable                         10.00%
Credit line capacity                         $ 60,000,000
Revolving Credit Facility | Line of Credit | New Credit Agreement                          
Debt Instrument [Line Items]                          
Credit line capacity         $ 100,000,000.0                
Long-term line of credit, noncurrent             $ 50,600,000 $ 50,600,000          
Remaining borrowing capacity             $ 15,700,000 $ 15,700,000          
Commitment fee percentage         0.50%                
Swingline | Line of Credit | New Credit Agreement                          
Debt Instrument [Line Items]                          
Credit line capacity         $ 20,000,000.0                
Letter of Credit | Line of Credit | New Credit Agreement                          
Debt Instrument [Line Items]                          
Credit line capacity         $ 20,000,000.0                
LIBOR | Revolving Credit Facility | Line of Credit | New Credit Agreement                          
Debt Instrument [Line Items]                          
Basis spread on variable rate         2.50%                
LIBOR, First 12 Months | Revolving Credit Facility | Line of Credit | New Credit Agreement                          
Debt Instrument [Line Items]                          
Basis spread on variable rate         0.35%                
LIBOR Thereafter | Revolving Credit Facility | Line of Credit | New Credit Agreement                          
Debt Instrument [Line Items]                          
Basis spread on variable rate         0.50%                
LIBOR, First 12 Months, Adjusted for Eurocurrency Liabilities | Revolving Credit Facility | Line of Credit | New Credit Agreement                          
Debt Instrument [Line Items]                          
Basis spread on variable rate         1.35%                
LIBOR, Thereafter, Adjusted for Eurocurrency Liabilities | Revolving Credit Facility | Line of Credit | New Credit Agreement                          
Debt Instrument [Line Items]                          
Basis spread on variable rate         1.50%                
Common Stock | Convertible Debt | Notes Due February 1, 2033                          
Debt Instrument [Line Items]                          
Shares issued on converted debt (in shares) | shares                   21,539,873      
Dr Frost | Line of Credit | Unsecured Debt                          
Debt Instrument [Line Items]                          
Credit line capacity                         $ 60,000,000
Repayments of lines of credit $ 28,800,000